CD269/BCMA Antibody (YA4672)
(Synonyms: TNFRSF17; BCM; BCMA; Tumor necrosis factor receptor superfamily member 17; B-cell maturation protein; CD269; CD269 nanobody; BCMA nanobody; )CD269/BCMA Antibody (YA4672) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CD269/BCMA.
-
Host:
Mouse
-
Application:
FC, ELISA
-
Reactivity :
Human
-
Formulation:
Supplied in Phosphate-buffered solution.
-
Conjugation:
Non-conjugated
Applications
| Application |
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
FC
FC: Flow Cytometry
|
|---|---|---|
| Dilution Ratio | 1:5000-100000 | 1-2μg/Test |
Product Details
CD269/BCMA Antibody (YA4672) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CD269/BCMA.
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman
Purified recombinant Human CD269
affinity purified.
Non-conjugated
Unmodified
Product Properties
-
Appearance
Liquid
-
Formulation
Supplied in Phosphate-buffered solution.
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
CD269/BCMA receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes B-cell survival and plays a role in the regulation of humoral immunity. Activates NF-kappa-B and JNK
-
Subcellular Localization
Cell membrane; Single-pass type III membrane protein; Endomembrane system; Single-pass type III membrane protein
-
Expression
Tissue_specificity:It is expressed in mature B cells, but not in T cells or monocytes. -
Isoforms & Post-Translational Modification
Q02223 has 2 isomers: Q02223-1: 20165 Da (predicted); Q02223-2: 14843 Da (predicted).
-
Subunit
Associates with TRAF1, TRAF2, TRAF3, TRAF5 and TRAF6
-
SwissProt ID
-
Synonyms
TNFRSF17; BCM; BCMA; Tumor necrosis factor receptor superfamily member 17; B-cell maturation protein; CD269; CD269 nanobody; BCMA nanobody;
Documentation